← Back to Search

Behavioral Intervention

Nutrition and Exercise App for Encephalopathy

N/A

Waitlist Available

Led By Puneeta Tandon, MD

Research Sponsored by University of Alberta

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 weeks

Awards & highlights

Study Summary

This trial evaluates an app to help people manage their cirrhosis through personalized nutrition and exercise.

Eligible Conditions

Encephalopathy
Liver Cirrhosis

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Participant Retention/Adherence

Secondary outcome measures

6-MWT

Program Satisfaction

Other outcome measures

Chair Sit-to-Stand

Thigh Muscle Measures

Trial Design

1Treatment groups

Experimental Treatment

Group I: Nutrition and Exercise AppExperimental Treatment1 Intervention

The exercise and nutrition app intervention will be provided to study participants. The app offers self-directed and supervised (virtual) programming to support nutrition and exercise self-management. Each participant follows a program that has been tailored to their overall health, physical function, and needs.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Nutrition and Exercise app

2021

N/A

~30

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of AlbertaLead Sponsor

886 Previous Clinical Trials

384,751 Total Patients Enrolled

Canadian National Transplant Research ProgramOTHER

7 Previous Clinical Trials

1,503 Total Patients Enrolled

Nutricia FoundationOTHER

11 Previous Clinical Trials

1,272 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are any new participants being inducted into this research endeavor?

"Clinicaltrials.gov reveals that, as of 11/25/2022, this research is no longer actively recruiting participants; however, there are an abundance of 589 other trials open for enrollment at the moment. This trial was posted on 4/20/2021."

Answered by AI

Recent research and studies

Liver InternationalJournal

Sarcopenic Obesity in Cirrhosis-the Confluence of 2 Prognostic Titans

Eslamparast, Tannaz, Aldo J. Montano-Loza, Maitreyi Raman, and Puneeta Tandon. 2018. “Sarcopenic Obesity in Cirrhosis-the Confluence of 2 Prognostic Titans”. Liver International. Wiley. doi:10.1111/liv.13876.

Journal of HepatologyJournal

Exercise in Cirrhosis: Translating Evidence and Experience to Practice

Tandon, Puneeta, Kathleen Patricia Ismond, Kenneth Riess, Andres Duarte-Rojo, Bandar Al-Judaibi, Michael Andrew Dunn, Jennifer Holman, et al.. 2018. “Exercise in Cirrhosis: Translating Evidence and Experience to Practice”. Journal of Hepatology. Elsevier BV. doi:10.1016/j.jhep.2018.06.017.

Clinical Gastroenterology and HepatologyJournal

Eight Weeks of Exercise Training Increases Aerobic Capacity and Muscle Mass and Reduces Fatigue in Patients with Cirrhosis

Zenith, Laura, Neha Meena, Ailar Ramadi, Milad Yavari, Andrea Harvey, Michelle Carbonneau, Mang Ma, et al.. 2014. “Eight Weeks of Exercise Training Increases Aerobic Capacity and Muscle Mass and Reduces Fatigue in Patients with Cirrhosis”. Clinical Gastroenterology and Hepatology. Elsevier BV. doi:10.1016/j.cgh.2014.04.016.

Alimentary Pharmacology & TherapeuticsJournal